Meridian Bioscience Inc. (VIVO) Lowered to "Hold" at TheStreet

Meridian Bioscience Inc. (VIVO) Lowered to "Hold" at TheStreet


VIVO has been the subject of a number of other reports. Zacks Investment Research raised Meridian Bioscience from a "sell" rating to a "hold" rating in a research report on Wednesday, July 13th.



from Biotech News